Brief: Senzime Q4 Sales Up At Sek 28.3 Million
18/02/2026 07:44
Feb 18 (Reuters) - Senzime AB (publ) SEZI.ST: Q4 SALES SEK 28.3 MILLION Q4 ADJUSTED GROSS MARGIN 25.1% Q4 OPERATING PROFIT BEFORE DEPRECIATION ADJUSTED FOR INVENTORY WRITE-DOWN AMOUNTED TO MSEK -24.6 (-25.9) IN 2026, WE AIM FOR PROFITABILITY BY END OF YEAR GOALS FOR 2026 TO MAINTAIN STRONG SALES GROWTH IN LINE WITH RECENT YEARS AND ACHIEVE POSITIVE CASH-FLOW WITHIN Q4 Source text: ID:nMFN7pJpV6 Further company coverage: SEZI.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona